Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has been updated to a new version, v2.15.2, and the previous version, v2.15.0, has been removed. Additionally, a date of April 29, 2025, has been added.SummaryDifference1.0%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check32 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 19, 2025, while a date for March 25, 2025, has been removed.SummaryDifference1.0%
- Check75 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check89 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check97 days agoChange DetectedThe website has updated its status from 'Recruiting' to 'Active, not recruiting' as of January 29, 2025, reflecting a significant change in its operational status.SummaryDifference2%
Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.